Buscar resultados de ensayos clínicos

Patrocinado por

Purpura, Thrombotic Thrombocytopenic - 18 Studies Found

Estado Estudiar
Withdrawn Nombre del estudio: Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
Condición: Purpura, Thrombotic Thrombocytopenic
Fecha: 2012-12-12
Intervenciones:
  • Drug: Octaplas infusion and placebo (group 1)

Terminated Nombre del estudio: IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients
Condición: Purpura, Thrombotic Thrombocytopenic
Fecha: 2016-07-27
Intervenciones: Biological: HMed-IdeS One dose of 0.25 mg/kg BW HMed-IdeS on study day 0. Following and evaluation of ef
Completed Nombre del estudio: Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
Condición: Thrombotic Thrombocytopenic Purpura
Fecha: 2009-05-22
Intervenciones: Drug: rituximab Patients will be treated according to the recommendations of the Reference Centre for th
Active, not recruiting Nombre del estudio: Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
Condición: Thrombotic Thrombocytopenic Purpura
Fecha: 2008-07-09
Intervenciones:
  • Drug: Cyclosporine 2-3 mg/kg o
Completed Nombre del estudio: Study to Assess Efficacy and Safety of Anti-von Willebrand Factor Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Condición: Thrombotic Thrombocytopenic Purpura
Fecha: 2010-06-25
Intervenciones:
  • Biological: anti-vWF Nanobody

Completed Nombre del estudio: Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
Condición: Acquired Thrombotic Thrombocytopenic Purpura
Fecha: 2015-09-14
Intervenciones:
  • Biological: caplacizumab Other
Completed Nombre del estudio: The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
Condición: Thrombotic Thrombocytopenic Purpura (TTP)
Fecha: 2009-07-09
Intervenciones: Drug: Rituximab Concentrate for solution for infusion, Intravenous use, 375mg/m2, Maximum 8 weekly infus
Terminated Nombre del estudio: Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)
Condición: Thrombotic Thrombocytopenic Purpura (TTP)
Fecha: 2006-12-13
Intervenciones:
  • Biological: Uniplas Uniplas wi
Completed Nombre del estudio: Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Condición: Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Fecha: 2014-08-12
Intervenciones: Drug: Recombinant ADAMTS13 rADAMTS13 (a disintegrin and me
Completed Nombre del estudio: Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura
Condición: Thrombotic Thrombocytopenic Purpura
Fecha: 2012-03-08
Intervenciones: Biological: rituximab rituximab intravenously 100 mg every week for four doses
Next >>>